Notch Therapeutics Shuts Vancouver Lab, Lays Off 25 to Focus on Toronto and Seattle Operations

Notch Therapeutics is closing its Vancouver lab and laying off about 25 employees, with some offered relocation, to focus on its Toronto and Seattle offices and streamline operations amid challenging times. The company, founded in 2018 and developing stem cell-derived cancer immunotherapies, plans to grow its Seattle team after raising $85 million in Series A funding in 2021.